ğŸ“Š HEALTH TOPIC OF THE WEEK: WHOLE GENOME SEQUENCING

Consumer DNA tests check ~0.1% of your genome. WGS reads all 3 billion base pairsâ€”every gene, every variant, complete.

The Comparison:

ğŸ“Š 23andMe / Ancestry
~700,000 SNPs tested (0.02% of genome)
Pre-selected variants only
Miss rare and novel mutations
Can't be updated with new discoveries

ğŸ§¬ Whole Genome Sequencing
3+ billion base pairs read (100% of genome)
Every gene, every variant
Captures rare mutations
Can be reanalyzed as science advances

What WGS Reveals:

ğŸ’Š Pharmacogenomics â€” How you metabolize drugs
ğŸ—ï¸ Cancer risk genes â€” BRCA, Lynch syndrome, and beyond
â¤ï¸ Cardiac variants â€” Hypertrophic cardiomyopathy, arrhythmias
ğŸ§¬ Rare diseases â€” Often missed by standard testing
ğŸ‘¶ Carrier status â€” For family planning
ğŸ§  Neurological risk â€” Including rare variants
ğŸ”® Future discoveries â€” Your data grows more valuable over time
ğŸ“ˆ Polygenic risk scores â€” Combined effects of thousands of variants

The Economics:

The first human genome cost $3 billion (2003).

Today: ~$200-400 for WGS.

Once sequenced, your data can be reanalyzed for decades as new disease associations are discovered. It's a one-time investment with compounding returns.

The catch: Interpretation is everything. Raw data without expert analysis is just noise. You need AI-powered systems that can make sense of 3 billion data points.

ğŸ‘¨â€âš•ï¸ Physicians: Why aren't you using Bioscope.AI to offer true AI-powered precision medicine?

ğŸ§‘ Patients: Why isn't your physician using Bioscope.AI to maximize your healthy longevity?

#HealthTopic #WholeGenome #Genetics #PrecisionMedicine #Bioscope
